HCA Healthcare Inc. (NYSE:HCA) saw an upside of 0.65% to close Tuesday at $239.07 after adding $1.55 on the day. The 5-day average trading volume is 1,095,840 shares of the company’s common stock. It has gained $244.15 in the past week. An average of 1,635,750 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,347,898.
HCA’s 1-month performance is -7.23% or -$17.63 on its low of $236.03 reached on 10/06/21. The company’s shares have touched a 52-week low of $121.91 and high of $263.92, with the stock’s rally to the 52-week high happening on 09/17/21. YTD, HCA has achieved 45.37% or $74.61. However, the current price is down -9.42%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On Aug 05, 69 days have gone by since the last insider trading activity for HCA Healthcare Inc. (HCA). Englebright Jane D. (SVP and Chief Nursing Officer) most recently sold 4,018 shares at $250.12 per share on Aug 05. This transaction cost the insider $1,004,997. President-Physician Services, Cuffe Michael S., sold 2,500 shares at a price of $251.91 on Aug 03. Then, on Aug 03, Group President Hall Charles J sold 6,000 shares at a price of $252.94 per share. This transaction amounted to $1,517,640.
The company’s PE ratio for the last five years has touched a high of 17.95 and a low of 6.766. HCA stock has a beta of 1.65. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.38 while the price to cash flow ratio at 244.85.
HCA Healthcare Inc. pays an annual dividend of $1.92 per share. Its dividend yield is 0.80% and the payout ratio is 9.40%. HCA’s most recent quarterly dividend payment was made on Sep. 30, when it paid $0.48 a share compared with prior rate of $0.48, down 0.0% from last year’s. The company has boosted its dividend for the last 1 consecutive years with the latest dividend increase of $0.2122 reported on Tuesday February 2 2021.
It is projected that HCA Healthcare Inc.’s next ex-dividend date will be on 20-Dec. HCA is expected to distribute $0.48 as its next dividend.
HCA Healthcare Inc.’s quick ratio for the period ended June 29 was 1.20, with the current ratio over the same period at 1.40 meaning that HCA stock is able to fulfill its debt obligations. In terms of profitability, the gross margin trailing 12 months is 83.80%. The trailing 12-month EBITDA margin is 19.37% while for the period ending June 29; HCA Healthcare Inc.’s operating margin was 15.30%. The firm’s gross profit as reported stood at $43.16 billion against revenue of $51.53 billion.
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 23.33% to $14.44 billion, while revenue of $13.98 billion was 3.17% off the previous quarter. Analysts expected HCA to announce $3.16 per share in earnings in its latest quarter, but it posted $4.37, representing a 38.30% surprise. EBITDA for the quarter stood at more than $3.23 billion. HCA stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 46.37 billion, with total debt at $34.37 billion. Shareholders hold equity totaling $320.14 million
Let’s look briefly at HCA Healthcare Inc. (HCA) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 34.25% to suggest the stock is trending Neutral, with historical volatility in this time period at 25.46%.
The stock’s 5-day moving average is $239.76, reflecting a -1.66% or -$4.04 change from its current price. HCA is currently trading -6.13% above its 20-day SMA, +15.94% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -4.75% and +45.56% respectively.
Stochastic %K and %D was 12.22% and 15.74% and the average true range (ATR) pointed at 5.07. The RSI (14) points at 37.66%, while the 14-day stochastic is at 12.70% with the period’s ATR at 5.12. The stock’s 9-day MACD Oscillator is pointing at -2.87 and -7.30 on the 14-day charts.
In the most recent analyst report for HCA Healthcare Inc. (NYSE: HCA), SVB Leerink launched coverage with an Outperform rating. Analysts offering their rating for HCA stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate HCA as a “sell,”, while 8 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 17 have offered a “buy” rating.
What is HCA’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $224.00 and a high of $320.00, with their median price target at $275.00. Looking at these predictions, the average price target given by analysts is for HCA Healthcare Inc. (HCA) stock is $276.64.